Comparison of monthly minodronate versus weekly bisphosphonate on bone mineral density in women with postmenopausal osteoporosis

Not Applicable

• Conditions: Osteoporosis

• Registration Number: JPRN-UMIN000008035
• Lead Sponsor: Yamaguchi university graduate school of medicine, Department of orthopedic surgery

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-28
• Study Completion: 2014-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: Female
• Target Recruitment: 216

Inclusion Criteria

Not provided

Exclusion Criteria

1)Secondary osteoporotic patient and patients who had disorders such as other causes of low bone mineral density 2)Patients who had history of gastrectomy or broad gastrointestinal resection 3)Patients who diagnosed malignancy 4)Patients who had history of radiation to lumber or pelvic section 5)Patients who had an observation affecting bone mineral density using DXA 6)Patients who received therapy of IV bisphosphonate 7)Patients who received therapy of strontium or parathyroid hormone 8)Patients who took calcitonin within a month before this trial 9)Patients who is receiving therapy of oral steroid 10)Patients who is receiving therapy of biologics or DMARDs 11)Patients who have obstacles which delays esophagus passage of stricture of the esophagus or achalasia 12)Patients who have raised the upper part of the body for 30 minutes or it cannot be standing 13)Patients who have serum calcium levels 10.6 or more mg/L 14)Patients who have serum calcium levels 8.0 or less mg/L 15)Patients who have severe renal dysfunction (creatinine clearance levels below 30 mL/min)

Study & Design

• Study Type: Interventional
• Study Design: Not specified